Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Cannabidiol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/14/2021 2 0
Nitazoxanide Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/24/2020 5 1
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Dec/17/2020 7 0
Trifluoperazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 1 0
Thioridazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 1 0
Aripiprazole Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 1 0
Fluoxetine  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 3 0
Protoporphyrin IX Potential treatment - pre-clinical evidence Natural product Antiviral Dec/09/2020 1 0
Δ9-Tetrahydrocannabinol Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Dec/05/2020 2 0
mRNA-1273 Emergency use authorization Experimental Vaccine Dec/03/2020 4 0